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Amelogenesis imperfecta (AI) describes a heterogeneous group of inherited dental enamel defects reflecting
failure of normal amelogenesis. Ameloblastin (AMBN) is the second most abundant enamel matrix protein
expressed during amelogenesis. The pivotal role of AMBN in amelogenesis has been confirmed experimentally
using mouse models. However, no AMBNmutations have been associated with human AI. Using autozygosity
mapping and exome sequencing, we identified genomic deletion of AMBN exon 6 in a second cousin consan-
guineous family with three of the six children having hypoplastic AI. The genomic deletion corresponds to an
in-frame deletion of 79 amino acids, shortening the protein from 447 to 368 residues. Exfoliated primary teeth
(unmatched to genotype) were available from family members. Themost severely affected had thin, aprismatic
enamel (similar to that reported in mice homozygous for Ambn lacking exons 5 and 6). Other teeth exhibited
thicker but largely aprismatic enamel. One tooth had apparently normal enamel. It has been suggested that
AMBNmay function in bone development. No clinically obvious bone or other co-segregating health problems
were identified in the family investigated. This study confirms for the first time thatAMBNmutations cause non-
syndromic human AI and that mouse models with disrupted Ambn function are valid.
INTRODUCTION
Formation of dental enamel (amelogenesis) results in the most
mineralized tissue in the human body. Enamel can last a lifetime
even though it does not have the capacity for cellular repair. This
longevity reflects that enamel predominantly consists of highly
elongated crystals of substituted calcium hydroxyapatite that are
arranged within prisms (rods), which each chart the pathway of
a single ameloblast. This provides a tissue architecture that
allows enamel to resist the mechanical stresses associated with
daily masticatory function (1).
This developmental endpoint requires the deposition of an
organic enamelmatrix into a discrete extracellular compartment
within the developing tooth by epithelially derived ameloblasts,
which are part of the enamel organ (2). The secreted organic
matrix is predominantly amelogenin but also includes other
less abundant, but functionally critical proteins, including ame-
loblastin (AMBN). Matrix secretion is coincident with calcium
hydroxyapatite nucleation and early crystal growth. As amelo-
blasts secrete the matrix, there is instantaneous precipitation of
thin immature enamel crystals. Matrix secretion ceases once
the pre-determined enamel volume is completed. At this point
the matrix is approximately one-third mineral by weight and
mechanically weak. During a period of maturation, the enamel
matrix is degraded and removed allowing the initial crystals to
grow in width and thickness until the tissue is almost fully
occluded by mineral (1). On completion of enamel formation
the ameloblasts form the reduced enamel epithelium on the
tooth surface, which is lost at the time of tooth eruption (3).
Amelogenesis imperfecta (AI) (MIM 104530) is the term given
to a heterogeneous group of disorders characterized by failure of
normal amelogenesis, with a reported prevalence of between
1/700 and 1/14 000 (4,5). AImay have a profoundly negative func-
tional and emotional impact on individuals that may include pain
and difficulty in eating as well as social avoidance, distress and
low self-esteem (6). Dental care can be challenging and protracted.
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Basedonclinical features,AI canbe simply classified ashypo-
plastic or hypomineralized with the key distinction being the
volume of enamel matrix secreted during amelogenesis. Hypo-
plastic AI is characterized by a grossly diminished enamel
volume reflecting early failure of the enamel organ. In contrast,
in hypomineralized AI there is near normal enamel volume that
is characterized by failure of normal biomineralization. Within
this subtype, hypomaturation AI and hypomineralized AI are
characterized by brittle and soft enamel, respectively. Both
lead to premature enamel loss following tooth eruption. To date,
mutations in very few genes have been identified as a cause of
autosomal dominant, autosomal recessive or X-linked AI in
the absence of other co-segregating abnormalities (7–15).
AMBN (MIM ∗601259) is the second most abundant enamel
matrix protein after amelogenin, which is coded by AMELX
(MIM ∗300391) and AMELY (MIM ∗410000). Amelogenin
accounts for up to 90% of the enamel matrix protein content.
AMBN is known to play key roles in amelogenesis although
its exact role remains to be fully elucidated. Poor quality
enamel is characteristic of mouse models with deletion of
Ambn exons 5 and 6 (Ambn25,6/25,6) (16,17) and Ambn over-
expression (18). These models give insight into the underlying
failure of the enamelorganand the associatedAI.AMBN is there-
fore an excellent candidate AI gene, and human AI cohorts have
been screened for AMBN mutations (19–25). Unlike AMELX,
however, no disease causing genetic AMBN variants have so
far been reported. Here we report for the first time that AMBN
mutations cause non-syndromic human AI and confirm that
mouse models with disrupted Ambn function are valid.
RESULTS
Patient phenotype and SNP mapping
We identified a consanguineous Costa Rican family with general-
izedhypoplasticAI involving theprimaryand secondarydentitions,
in the absenceof co-segregating health problems (Fig. 1).DNAwas
obtained and extracted from eight samples using Oragene DNA
collection tubes (DNA Genotek, Kanata, Canada) according to
the manufacturer’s protocol.
GenomicDNA from individuals VI:2, VI:3 andVI:4was ana-
lysed using Affymetrix 6.0 SNP microarrays. Two shared
regions of homozygosity were identified using SNP Viewer
(http://sourceforge.net/projects/snpviewer/), these being a 14.5 Mb
region on chromosome 1p (Chr1: 11 698 902–26 171 473) and a
12.2 Mb region on chromosome 4q (Chr4: 71 230 491–
83 403 217). While no known AI genes lay within the chromo-
some 1 region, the chromosome 4 region contains a number of
genes encoding proteins with essential roles in tooth develop-
ment, including two, ENAM and C4orf26, already implicated
inAI. Sequencing of both genes however revealed nomutations.
Whole-exome sequencing
We therefore performedwhole-exome sequencing using a Sure-
Select All Exon XT reagent (Agilent Technologies, Edinburgh,
UK) on DNA from individual VI:2. Following alignment, pro-
cessing and duplicate removal, a mean depth of 40.12 reads
per base was observed in the shared homozygous regions, with
95.5% of coding bases covered by at least 5 reads. Indel and
single nucleotide variants within the candidate regions were
called in the VCF format using the UnifiedGenotyper function
of Genome Analysis Toolkit (GATK), identifying a total of
672 variants passing standard GATK filters. Using the dbSNP
database at NCBI (http://www.ncbi.nlm.nih.gov/projects/SNP/),
any variants present in dbSNP129 or with a minor allele fre-
quency ≥1% in dbSNP137 were filtered out as polymorphisms,
leaving just 46 variants. After filtering for nonsynonymous
variants, exonic insertions or deletions or variants at splice con-
sensus sites, only a single variant remained (chr1:17026040_
17026041insGCGGCGGCGGCGGCA)causing an in-frame in-
sertion of 15 bp in the Espin Pseudogene (ESPNP). However,
analysis of the surrounding sequence revealed that the insertion
waswithin a simple (CGG)n repeatwithmultiple reported repeat
number polymorphisms in dbSNP. The ESPNP variant was thus
considered an unlikely cause of disease in this family.
To confirm that sequence reads for all exons in the homozy-
gous regions were present, the ‘DepthOfCoverage’ function of
GATK was used to analyse the average read-depth across each
exon. Using an in-house perl script, the results were compared
with five unrelated exomes processed in an identical manner as
the sample from individual VI:2. This revealed a lack of reads
(average 0.56 reads/base) in exon 6 of the AMBN gene
(NM_016519), compared with an average of 230 reads/base
(range 200–269) in the five comparison exomes. Investigation
of the remaining exons of AMBN revealed that read depth for
these exons in individual VI:2 was similar to that in comparison
exomes.
PCR and sanger sequencing
To investigate the lack of reads further, PCR amplification using
primers designed to amplify exon 6, plus 50 bp of flanking
intron, was performed. The results corroborated the exome
data in that no product was observed in the affected members
of the family, whereas amplification was successful in unaffect-
ed family members. A control PCR, designed to amplify part of
the P53 gene, was successful in all affected and unaffected
samples (Fig. 2A). To determine the cause of this result, a long
range PCR was undertaken with primers designed to span from
exons5 to7 inAMBNgenomicDNA.Sequencingof the resulting
product revealed a deletion of 2347 bp (c.294 + 139_531 +
478del) encompassing all 237 bp of exon 6 and 2110 bp of flank-
ing sequence either side (Fig. 2B). To confirm the loss of exon 6,
and to determine the effect this has on transcription of AMBN
mRNA, patient leukocyte cDNA was obtained. While cDNA
amplificationwith control primerswas successful, amplification
ofAMBN products failed in both patient and control cDNA,most
probably due to insufficient expression of the mRNA in blood.
The deletion identified is predicted to create an in-frame dele-
tion of 79 amino acids (p.Tyr99_Glu177del), shortening the
protein from 447 to 368 amino acids (Fig. 2C). Based on this
result, we screened all coding exons and flanking introns of
AMBN in an additional 13 recessive hypoplastic AI samples,
but no further mutations were identified.
Enamel phenotyping
On clinical examination of the teeth, the three family members
homozygous for the mutation (VI:2, VI:3 and VI:4) exhibited
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rough hypoplastic AI of the permanent dentition. The child het-
erozygous for the mutation (VI:5) exhibited someminor enamel
defects that were very different from the hypoplastic AI of the
three affected siblings. Individuals VI:1 and VI:6 did not carry
the mutation and exhibited a normal dentition (Supplementary
Material, Fig. S1).
Five deciduous teeth (teeth 1–5) retained by the family after
natural exfoliationweremade available for phenotypic character-
ization.Nophotographsof thedeciduous teethwhenpresent in the
mouthswereavailable for review.The teeth could thereforenotbe
matched to individual family members VI:1–VI:6 and accord-
ingly, phenotypes could not be matched unambiguously with
a specific genotype. High resolution-CT scanning (Fig. 3 and
Supplementary Material, Videos 1–5) identified that tooth 1
exhibited a normal enamel layer in terms of thickness and
mineral density [density ¼ 2.82 g+ 0.073 g/cm3 compared
with 2.69–2.92 g/cm3—the range previously reported for
deciduous enamel (26)] consistent with originating from either
individual V:I or VI:6 (both normal genotype). The enamel cov-
ering teeth 2 and 3 was pitted and varied in thickness over the
crown from near normal to areas where thickness was reduced
to tens of microns and in some places was absent altogether.
The enamel covering teeth 4 and 5 was thinner (50 mm or
less) or absent to a greater degree than in teeth 2 and 3. Mean
mineral density was significantly reduced in teeth 2–5 relative
to tooth 1 (Fig. 3).
On SEM, tooth 1 exhibited the prismatic structure character-
istic of normal human enamel (Fig. 4). Thicker areas of
enamel on the abnormal teeth (e.g. tooth 2) lacked normal pris-
matic structure. However, occasionally structures were visible
that resembled poorly formed prisms (inset; Fig. 4 tooth 2).
Reduced enamel thickness and absence of any normal architec-
turewas evenmore pronounced in enamel covering teeth 4 and5.
Differential post eruptive wear may have affected the enamel
thickness as measured, but would not account for lack of the
normal prismatic enamel structure in teeth 2–5. No permanent
teeth were available for analysis and so it is unknown what
impact the AMBN deletion (heterozygous or homozygous)
would have on the ultrastructure of the enamel recorded in the
clinical photographs presented.
Figure1.Familypedigreeanddentalphenotype. (A) Pedigreeof theCostaRican family investigated.Affected familymembersare shaded. (B)Thepermanent teethof
affected individuals (VI:3 presented)were characterized bygeneralized hypoplasticAI involving all teeth. (C) The enamel surfacewas rough, but hard (VI:3 andVI:4
presented in Ci and Cii, respectively). Note: some teeth have been restored with metal or tooth-coloured restorations (examples marked∗).
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Figure 2.Genotyping of themutation and identification of the deletion breakpoints. (A) PCR analysis of AMBN exon 6 inmembers of the family investigated. Amp-
lification of exon 6 alonewas only observed in individualswith clinically normal teeth and a normalAMBN genotype,whereas PCRwith primers spanning fromexons
5 to 7 amplified a product of 794 bp in affected and carrier individuals only, reflecting loss of exon 6. Bands obtained with primers amplifying P53 are shown as a
positive control for each sample. (B) Sequence electropherograms of mutant and wild-type alleles to identify the deletion breakpoints. Comparison of the mutant
sequence with a control sequence revealed a deletion of 2347 bp spanning exon 6 and the majority of the surrounding introns either side. The deletion begins
114 bp from the end of exon 5. (C) Wild-type amino acid sequence of AMBN exon 6. Important domains, which are likely to play a key role in the function of the
mature protein, are labelled. Schematics of the exon-intron layout of wild-type and the mutant genomic DNA sequences are also shown, showing the lack of exon
6 and the approximate break-points with respect to the local exons.
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DISCUSSION
We have identified a family from Costa Rica segregating hypo-
plastic AI in an autosomal recessive manner. SNP genotyping
revealed a region on chromosome 4 shared by all affected indi-
viduals and whole-exome sequencing showed a lack of reads
across AMBN exon 6. Further investigation showed this to be
due to a 2347 bp deletion encompassing the whole of exon 6
and flanking intronic sequence either side. A screen of 13 add-
itional hypoplastic AI families revealed no further mutations.
A mouse model homozygous for Ambn lacking exons 5 and
6 (Ambn25,6/25,6) has a similar phenotype to the most severe
phenotype reported here with secretion of only a thin dysplastic
layer of mineralized tissue that is rough and pitted and devoid of
normal prismatic structure (16,17). Heterozygous Ambn+5,6/25,6
mice had prismatic enamel of near normal thickness but that was
significantly less-well mineralized compared with wild-type
(16,17). Likewise here, mineral density is significantly decreased
in all teeth 2–5 compared with unaffected tooth 1. Heterozygous
Ambn+5,6/25,6 mice had an ordered prismatic structure. In con-
trast, the severely disrupted prismatic structure in teeth 2 and 3
led us to tentatively conclude that these may be from family
member VI:5 who is heterozygous for the AMBNmutation.
AI may co-segregate with other clinical phenotypes that may
not always be obvious. No co-segregating conditions were iden-
tified from speaking with the family. Potential roles for AMBN
in bone development and remodelling /repair have been reported
(27,28). However, the role ofAMBN in bone is unconfirmed and
mouse models of loss of Ambn function did not have obvious
bone defects including abnormalities of bone remodelling or
repair (16,17,29,30).This is inkeepingwith thefindings reported
here. On discussion with the family there were no obvious bone
abnormalities and nothing was identified that warranted further,
detailed clinical evaluation. The oldest affected individual was
entering adulthood when assessed and any effect of the ABMN
mutation may have on bone may not become apparent until
later in life.
The precise mechanisms underlying the enamel defect in this
family are unclear. Although the deletion is in-frame, the loss of
79 amino acids in a part of AMBN believed to have important
functions can be expected to have a significantly detrimental
impact on AMBN function.
In wild-type rodents expression of Ambn by ameloblasts is
highest during the secretory stage of amelogenesis and
diminishes during the maturation phase (28,31). Following
secretion, Ambn is cleaved into C- and N-terminus fragments by
enamel matrix proteases including Mmp20. The basic 17KDa
N-terminus fragment and its processing products are highly
aggregative and can be immunolocalized to the sheath space
surrounding enamel prisms. The acidic C-terminus is degraded
and removed from the matrix soon after secretion. It has been
suggested that the N-terminal fragments have a key role in the
Figure 3.High resolutionX-ray CT analysis of exfoliated teeth 1–5. Typical CT sections through the teeth are presented using false colour calibratedwith respect to
mineral density to generatemineral densitymaps.Mean enamelmineral density for each tooth is also shown graphically. Tooth 1 exhibits an enamel layer apparently
normal in structure and density. Teeth 2 and 3 exhibit an obvious enamel covering though it is thinner in many areas, chipped, absent in places and is significantly
reduced in mineral density compared with tooth 1 (P , 0.0001). Teeth 4 and 5 exhibit an even thinner covering of enamel with enamel absent in some areas.
Again enamel mineral density is significantly lower than in tooth 1 (P , 0.0001). The only non-significant differences in enamel mineral density occur between
teeth 4 and 5. Videos of 3D rendered CT data showing surface detail and internal structure of all teeth are available as Supplementary Material.
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formationof theprismsheath (32,33).Biological activity hasalso
been associatedwith 17 KDaN terminal pigAMBNwith native and
synthetic17 KDaAMBNpeptidesbeingabletoinducealkalinephos-
phatase activity in human periodontal ligament cells; this activity
appears to reside in a domain (-VEGPMVQQQVAPSEK-) near
the C-terminal of the molecule (34). The corresponding region in
human AMBN is deleted in the human AMBN26/26 mutation
reportedhere and in theAmbn25,6/25,6mousemutant previously
reported. It is unknown if the N-terminal 17 kDa fragment has
any role in inducing alkaline phosphatase expression during
amelogenesis but the enamel organ expresses tissue non-specific
alkaline phosphatase (35) and alkaline phosphatase activity is
readily detected in developing enamel matrix (36).
Msx2 is a transcriptional repressor of mouse Amelx (37). In
Ambn25,6/25,6 mice ameloblast Msx2 expression remains
abnormally elevated during the secretory stage of amelogenesis
and appears to dramatically down-regulate Amelx expression
without affecting expression of other enamel matrix proteins
(30). However, since Amelx accounts for up to 90% of the
enamel matrix protein its down-regulation due to elevated Msx2
activity might partially account for the thin enamel in
Ambn25,6/25,6 mice and possibly AMBN26/26 teeth 4 and 5
reported here.
AMBN has also been implicated in cell adhesion. In
Ambn25,6/25,6 mice, the ameloblast monolayer detaches from
the enamel matrix (30) and the specialized ameloblast process
(Tomes process) responsible for orchestrating prismatic
enamel formation fails to develop (16). The ameloblasts lose
their normal morphology and begin proliferating abnormally
to produce a multi-cell layer (30) and normal enamel matrix
Figure 4. SEM of representative exfoliated teeth. Tooth 1 exhibits normal enamel architecture comprising prisms (rods) of individual enamel crystallites classically
described in numerous research publications and text books. The SEM representative of the thicker enamel found covering tooth 2 is lacking the obvious long range
order and structure that characterizes normal enamel.However, very occasional areas exhibiting prism-like structures are present (indicated by arrows on insetmicro-
graph).Wherepresent, the enamelcovering teeth4and5 is thin andexhibitsnostructural similarities tonormal enamel.Thewhitehorizontal lines showwhere separate
micrographs have been collaged to create a wider field of view.
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secretion fails resulting in the hypoplasticAI phenotype. Similar
phenotypes are also observed in animal models over-expressing
Ambn (18). The mechanisms responsible for this detachment
have yet to be elucidated. AMBN has been reported to interact
with cells via binding sites for fibronectin (38) and heparin
(39) but the role played by such interactions in amelogenesis is
unclear.
In summary, the identification of a homozygous 2347 bp
genomic deletion in AMBN identifies for the first time that
AMBN mutations cause autosomal recessive hypoplastic human
AI. The mechanisms causing AI in this case are unclear but may
involve the critical role of AMBN in ameloblast attachment,
maintenance of the ameloblast phenotype and repression of tran-
scription factors that otherwise down-regulate amelogenin
expression. Although detailed analysis of skeletal tissues was
not undertaken, there was an absence of obvious bone or other
defects associatedwith thismutation in these young adults. A het-
erozygous carrier for the 2347 bp genomic deletion inAMBNwas
identified.Although therewere someminor enamel abnormalities
in the permanent dentition, this individual did not have hypo-
plastic AI. Comparison of the enamel phenotype of exfoliated
deciduous teeth suggests that mouse models with disrupted Ambn
function are valid.
MATERIALS ANDMETHODS
Patients
Affected individuals and familymemberswere recruited follow-
ing informedconsent in accordancewith the principles outlinedby
the declaration of Helsinki, with local ethical approval. Genomic
DNAsampleswereobtainedusingOragenewDNAsamplecollec-
tionkits (DNAGenotek,ONT,Canada) according to themanufac-
turer’s instructions.
SNP analysis
Genomic DNA from three affected individuals were genotyped
using Affymetrix 6.0 SNP microarrays by AROS Applied Bio-
technology (Aarhus, Denmark). Shared regions of homozygos-
ity were identified using SNP Viewer (http://sourceforge.net/
projects/snpviewer/).
Whole-exome sequencing and analysis
DNA from individual VI:2. Threemicrograms of genomicDNA
were processed according to the Agilent SureSelect Library Prep
protocol (Agilent Technologies, CA, USA). Sequencing was per-
formed using a 100 bp paired-end protocol on an Illumina HiSeq
2500 sequencer (Illumina, CA, USA). The resulting fastq files
were aligned to the human reference genome (GRCh37) using
the Bowtie2 software (40). This alignment was processed in the
SAM/BAM format using Picard and The GATK java programs
(41–43).
Tooth ultrastructure analysis
Five deciduous teeth (teeth 1–5) retained by the family after
natural exfoliationweremade available for phenotypic character-
ization.Nophotographsof thedeciduous teethwhenpresent in the
mouths were available for review. These teeth were subjected to
high resolutionCT using a Skyscan 1172 (Brucker, UK) operated
at 100 kV; source current of 100 mA,usingaAl/Cufilter to reduce
beam hardening. CT slices were reconstructed using the Skyscan
Recon software and rendered as 3D videos using the Skyscan
CTVoxsoftware.TheCTimageswerecalibratedusingacalibration
phantom comprising of a section of a mouse incisor and the mean
mineral density of enamel was determined using the ImageJ soft-
ware (http://imagej.nih.gov/ij/) by measuring the mineral density
of any surface material .2 g/cm3 present on 10 evenly spaced
CT slices taken through each tooth. Calibrated colour contour
maps of mineral density were also generated using ImageJ.
ForSEM, teethwere sectionedwith adiamonddisk and the cut
surfaces smoothed using fine carborundum paper. Specimens
were etched in 30% phosphoric acid for 20 s followed by thor-
ough rinsing in excess distilled water. Teeth were dried over-
night under vacuum and sputter coated with gold. Specimens
were observed using a Hitachi S-3400N scanning electron
microscope operated at an accelerating voltage of 20 kV.
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG Online.
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